在精神分裂症中Lumateperone的安全性和耐受性:叙述性审查
Jamal Montaser1, Srihas Tumu1, Venkata Yashashwini Maram Reddy2
1Psychiatry and Behavioral Sciences, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus
|December 8, 2025
概括
卢马特佩龙有效地治疗精神分裂症症状,副作用比较少. 这种新型抗精神病药物提供了更好的安全性,可能改善患者的坚持和结果.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于抗精神病副作用,精神分裂症的管理具有挑战性.
- 已建立的抗精神病药物通常会导致体重增加,镇静和额外金字塔症状 (EPS).
研究的目的:
- 审查最近的临床证据,用于治疗精神分裂症的lumateperone.
- 与现有治疗方法相比,评估lumateperone的疗效和安全性.
主要方法:
- 叙事综述综合了最近的临床试验数据.
- 评估研究设计,结果和跨试验的一致性.
主要成果:
- 卢马特佩龙可以减少核心精神分裂症症状.
- 它具有良好的安全性,具有较低的代谢和运动副作用风险.
- 由于减少了不良影响,可能会改善长期坚持.
结论:
- 卢马特佩龙作为一种有效的抗精神病药物,具有更好的耐受性.
- 对于那些对常规抗精神病药物反应不足的患者来说,它可能是一个有价值的选择.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
530
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
530
01:26Psychosis: Goals of Pharmacotherapy
446
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
446
01:28Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
01:28Psychosis and Antipsychotic Drugs: Overview
779
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
779
01:21Antipsychotic Drugs: Typical and Atypical Agents
710
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
710
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K